Imidazopyridines as selective CYP3A4 inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 22, Issue 4, 2012, Pages 1611-1614

  Song, Xinyi ^a   Li, Xiaohai ^a   Ruiz, Claudia H ^a   Yin, Yan ^a   Feng, Yangbo ^a   Kamenecka, Theodore M ^a   Cameron, Michael D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CYP3A4; CYP3A5; Cytochrome P450; Imidazopyridines

Indexed keywords

CYTOCHROME P450 3A4; IMIDAZOPYRIDINE DERIVATIVE;

ARTICLE; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; IC 50;

EID: 84862786407     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.12.125     Document Type: Article

References (10)

1. Qato, D. M.; Alexander, G. C.; Conti, R. M.; Johnson, M.; Schumm, P.; Lindau, S. T. JAMA 2008, 300, 2867.
2. Zechnich, A. D.; Hedges, J. R.; Eiselt-Proteau, D.; Haxby, D. West J. Med. 1994, 160, 321.
3. Ekins, S.; Stresser, D. M.; Williams, J. A. Trends Pharmacol. Sci. 2003, 24, 161.
4. (a)Rendic, S. Drug Metab Rev 2002, 34, 83
5. (b) Williams, J. A.; Hyland, R.; Jones, B. C.; Smith, D. A.; Hurst, S.; Goosen, T. C.; Peterkin, V.; Koup, J. R.; Ball, S. E. Drug Metab. Dispos. 2004, 32, 1201.
6. (a)Stresser, D. M.; Broudy, M. I.; Ho, T.; Cargill, C. E.; Blanchard, A. P.; Sharma, R.; Dandeneau, A. A.; Goodwin, J. J.; Turner, S. D.; Erve, J. C.; Patten, C. J.; Dehal, S. S.; Crespi, C. L. Drug Metab. Dispos. 2004, 32, 105
7. (b) Pearson, J. T.; Wahlstrom, J. L.; Dickmann, L. J.; Kumar, S.; Halpert, J. R.; Wienkers, L. C.; Foti, R. S.; Rock, D. A. Chem. Res. Toxicol. 2007, 20, 1778
8. (c) Khan, K. K.; He, Y. Q.; Correia, M. A.; Halpert, J. R. Drug Metab. Dispos. 2002, 30, 985.
9. Daly, A. K. Clin. Pharmacokinet. 2006, 45, 13.
10. Zhao, Y.; Song, M.; Guan, D.; Bi, S.; Meng, J.; Li, Q.; Wang, W. Transplant Proc. 2005, 37, 178.